Trials / Unknown
UnknownNCT03287570
Efficacy and Safety of Cettum for Knee Osteoarthritis
Clinical Research on the Efficacy and Safety of Cettum on Knee Osteoarthritis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 138 (estimated)
- Sponsor
- Eun Jung Kim · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is verify the efficacy and safety of Cettum (Electric moxibustion) for patients with knee osteoarthritis.
Detailed description
The investigator targets the patients with knee osteoarthritis. After treatment in 3 groups - Cettum treatment, traditional indirect moxibustion treatment, and usual care groups - the investigators will compare the effects of pain relieving and daily performing improvement. So the investigators will confirm the efficacy of Cettum, and further the best treatment method. In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cettum | The treatment is applied twice a week for 15 minutes for 6 weeks (12 sessions). 6 points (ST36, ST35, EX-LE4, SP9, SP10, ST34) are used for all the patients assigned to this group and investigator can be added up to 2 points depending on the patient condition. Electric moxibustion, Cettum (20X28X18mm) manufactured by K-medical Co.(Korea) is used. |
| PROCEDURE | Traditional indirect moxibustion | The treatment is applied twice a week for 6 weeks (12 sessions). 6 points (ST36, ST35, EX-LE4, SP9, SP10, ST34) are used for all the patients assigned to this group and investigator can be added up to 2 points depending on the patient condition. Traditional indirect moxibustion, Taekeukttum manufactured by Haenglim Seowon Medical Co.(China) is used. A total of three moxibustion cones are applied indirectly to each point per treatment session. |
| OTHER | Usual care | The patients in this group maintain the usual treatment and self-care. |
Timeline
- Start date
- 2017-09-20
- Primary completion
- 2018-08-01
- Completion
- 2018-12-01
- First posted
- 2017-09-19
- Last updated
- 2017-10-19
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03287570. Inclusion in this directory is not an endorsement.